154 related articles for article (PubMed ID: 16918998)
1. Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha.
Wada Y; Yoshida K; Hihara J; Konishi K; Tanabe K; Ukon K; Taomoto J; Suzuki T; Mizuiri H
Cancer Sci; 2006 Oct; 97(10):1037-43. PubMed ID: 16918998
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines.
Wada Y; Yoshida K; Tsutani Y; Shigematsu H; Oeda M; Sanada Y; Suzuki T; Mizuiri H; Hamai Y; Tanabe K; Ukon K; Hihara J
Oncol Rep; 2007 Jan; 17(1):161-7. PubMed ID: 17143494
[TBL] [Abstract][Full Text] [Related]
3. Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy.
Nawa M; Osada S; Morimitsu K; Nonaka K; Futamura M; Kawaguchi Y; Yoshida K
Anticancer Res; 2012 Jan; 32(1):13-9. PubMed ID: 22213283
[TBL] [Abstract][Full Text] [Related]
4. Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia.
Yanagihara K; Fukuda Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Tsukamoto K; Yamada Y; Kamhira S; Kohno S
Exp Lung Res; 2007 Mar; 33(2):71-80. PubMed ID: 17454103
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics.
Zeiher BG; Matsuoka S; Kawabata K; Repine JE
Crit Care Med; 2002 May; 30(5 Suppl):S281-7. PubMed ID: 12004249
[TBL] [Abstract][Full Text] [Related]
6. Effects of sivelestat sodium hydrate on the reduction of radiation pneumonitis.
Shimbo T; Inomata T; Takahashi M; Tatsumi T; Uesugi Y; Narabayashi I; Sonobe H
Int J Mol Med; 2007 Dec; 20(6):817-22. PubMed ID: 17982688
[TBL] [Abstract][Full Text] [Related]
7. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
[TBL] [Abstract][Full Text] [Related]
8. Effect of sivelestat, an inhibitor of neutrophil elastase, on rapidly progressive glomerulonephritis.
Soma J; Sato K; Suzuki M; Segawa Y; Miyate Y
Clin Nephrol; 2003 Aug; 60(2):149-50. PubMed ID: 12940621
[No Abstract] [Full Text] [Related]
9. Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice.
Sakashita A; Nishimura Y; Nishiuma T; Takenaka K; Kobayashi K; Kotani Y; Yokoyama M
Eur J Pharmacol; 2007 Sep; 571(1):62-71. PubMed ID: 17599828
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method.
Shimoda M; Iwasaki Y; Okada T; Sawada T; Kubota K
Eur J Pharmacol; 2008 Jun; 587(1-3):248-52. PubMed ID: 18374331
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.
Akamoto S; Okano K; Sano T; Yachida S; Izuishi K; Usuki H; Wakabayashi H; Suzuki Y
Surg Today; 2007; 37(5):359-65. PubMed ID: 17468814
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase inhibitor prevents endotoxin-induced liver injury following experimental partial hepatectomy.
Kwon AH; Qiu Z
Br J Surg; 2007 May; 94(5):609-19. PubMed ID: 17315175
[TBL] [Abstract][Full Text] [Related]
13. The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.
Tsujii S; Okabayashi T; Shiga M; Takezaki Y; Sugimoto T; Kobayashi M; Hanazaki K
World J Surg; 2012 May; 36(5):1122-1127. PubMed ID: 22366983
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB.
Hagiwara S; Iwasaka H; Hidaka S; Hasegawa A; Noguchi T
Inflamm Res; 2009 Apr; 58(4):198-203. PubMed ID: 19169649
[TBL] [Abstract][Full Text] [Related]
15. Improving effect of Sivelestat on lipopolysaccharide-induced lung injury in rats.
Yuan Q; Jiang YW; Fang QH
APMIS; 2014 Sep; 122(9):810-7. PubMed ID: 24484066
[TBL] [Abstract][Full Text] [Related]
16. The neutrophil elastase inhibitor sivelestat suppresses accelerated gastrointestinal tumor growth via peritonitis after cecal ligation and puncture.
Kumagai K; Saikawa Y; Takeuchi H; Suda K; Fukuda K; Nakamura R; Takahashi T; Kawakubo H; Wada N; Miyasho T; Kitagawa Y
Anticancer Res; 2013 Sep; 33(9):3653-9. PubMed ID: 24023292
[TBL] [Abstract][Full Text] [Related]
17. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
18. A neutrophil elastase inhibitor, sivelestat, improves leukocyte deformability in patients with acute lung injury.
Inoue Y; Tanaka H; Ogura H; Ukai I; Fujita K; Hosotsubo H; Shimazu T; Sugimoto H
J Trauma; 2006 May; 60(5):936-43; discussion 943. PubMed ID: 16688053
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers.
Ho AS; Chen CH; Cheng CC; Wang CC; Lin HC; Luo TY; Lien GS; Chang J
Oncotarget; 2014 Jan; 5(2):473-80. PubMed ID: 24457622
[TBL] [Abstract][Full Text] [Related]
20. The neutrophil elastase inhibitor, sivelestat, attenuates sepsis-related kidney injury in rats.
Li G; Jia J; Ji K; Gong X; Wang R; Zhang X; Wang H; Zang B
Int J Mol Med; 2016 Sep; 38(3):767-75. PubMed ID: 27430552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
